EcoDrugPlus

Il2 Inducible T Cell Kinase

Ensembl ID : ENSLCAG00010005734
Gene Symbol: LOC108882785
4 Cross references
205 Possible Orthologues:

Imp (Inosine 5'-Monophosphate) Dehydrogenase 1a

Ensembl ID : ENSLCAG00010011746
Gene Symbol: IMPDH1A
4 Cross references
258 Possible Orthologues:

Imp (Inosine 5'-Monophosphate) Dehydrogenase 1b

Ensembl ID : ENSLCAG00010015454
Gene Symbol: LOC108889258
4 Cross references
257 Possible Orthologues:

Imp (Inosine 5'-Monophosphate) Dehydrogenase 2

Ensembl ID : ENSLCAG00010027787
Gene Symbol: LOC108882556
4 Cross references
200 Possible Orthologues:

Janus Kinase 1

Ensembl ID : ENSLCAG00010009784
Gene Symbol: LOC108897047
4 Cross references
212 Possible Orthologues:

Janus Kinase 2a

Ensembl ID : ENSLCAG00010003367
Gene Symbol: JAK2A
4 Cross references
199 Possible Orthologues:

Janus Kinase 2b

Ensembl ID : ENSLCAG00010017718
Gene Symbol: JAK2B
1 Cross references
194 Possible Orthologues:

Kit Proto-Oncogene, Receptor Tyrosine Kinase B

Ensembl ID : ENSLCAG00010027617
Gene Symbol: KITB
1 Cross references
200 Possible Orthologues:

Lyn Proto-Oncogene, Src Family Tyrosine Kinase

Ensembl ID : ENSLCAG00010007909
Gene Symbol: LYN
1 Cross references
195 Possible Orthologues:

Malt1 Paracaspase

Ensembl ID : ENSLCAG00010017298
Gene Symbol: MALT1
1 Cross references
195 Possible Orthologues:

Map Kinase-Activated Protein Kinase 2

Ensembl ID : ENSLCAG00010018297
Gene Symbol: LOC108889533
4 Cross references
174 Possible Orthologues:

Mapk Activated Protein Kinase 2

Ensembl ID : ENSLCAG00010012524
Gene Symbol: MAPKAPK2
4 Cross references
187 Possible Orthologues:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).